Malabsorption News

ORLANDO, Fla. — Incidence and risk factors for cardiovascular disease were less prevalent among patients with celiac disease than controls in a study presented at Digestive Disease Week.

The FDA’s Gastrointestinal Drugs Advisory Committee today unanimously agreed that Gattex offers a clinical benefit that outweighs potential risks in patients with short bowel syndrome.

Patients with celiac disease experienced less-severe gastrointestinal symptom escalation following a gluten challenge while taking low doses of larazotide acetate in a recent study.

Persistent intraepithelial lymphocytosis remained common among patients with celiac disease despite a gluten-free diet in a recent study.

SAN DIEGO — Patients with celiac disease may be less likely to develop non-insulin dependent diabetes mellitus or metabolic syndrome, according to data presented at the 2012 Digestive Disease Week Annual Meeting.

A prospective study investigating a cemented titanium femoral stem indicates aseptic loosening as the most common cause of revision and shows inferior 10-year survivorship compared to modern uncemented implants. “We think the 10-year survivorship of the stem does not match those of collarless polished tapered stems or modern uncemented implants and we recommend continuing surveillance of these patients,” Benjamin Bloch stated in his presentation at the British Orthopaedic Association and the Irish Orthopaedic Association Combined Meeting 2011.

Vitamin B12 levels, often depleted due to metformin-induced malabsorption, should be monitored on a yearly basis in patients with diabetes receiving long-term metformin therapy, David S.H. Bell, MD, suggested in a case report published in the Southern Medical Journal.

Obese individuals who underwent Roux-en-Y gastric bypass had decreased bone mineral density at the femoral neck and total hip at one year in a new study.